Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel Levi

Showing results (301-310 of 394) with videos related to

Pageof 40
Sort By:
BMC Pulmonary Medicine|August 17, 2012
Early intravenous unfractionated heparin and outcome in acute lung injury and acute respiratory distress syndrome: a retrospective propensity matched cohort studyJorrit J Hofstra, Alexander P J Vlaar, David J Prins, et al.
British Journal of Haematology|February 12, 2004
Recombinant factor VIIa reverses the anticoagulant effect of the long-acting pentasaccharide idraparinux in healthy volunteersNick R Bijsterveld, Roel Vink, Benien E van Aken, et al.
Critical Care Medicine|May 9, 2012
Endogenous tissue-type plasminogen activator impairs host defense during severe experimental Gram-negative sepsis (melioidosis)*Liesbeth M Kager, W Joost Wiersinga, Joris J T H Roelofs, et al.
Thrombosis and Haemostasis|December 18, 2015
Supportive management strategies for disseminated intravascular coagulation. An international consensusAlessandro Squizzato, Beverley J Hunt, Gary T Kinasewitz, et al.
American Journal of Respiratory Cell and Molecular Biology|April 19, 2008
Endogenous beta-adrenergic receptors inhibit lipopolysaccharide-induced pulmonary cytokine release and coagulationIda A J Giebelen, Masja Leendertse, Mark C Dessing, et al.
Thrombosis and Haemostasis|November 4, 2011
Bleeding risk assessment and management in atrial fibrillation patients. Executive Summary of a Position Document from the European Heart Rhythm Association [EHRA], endorsed by the European Society of Cardiology [ESC] Working Group on ThrombosisGregory Y H Lip, Felicita Andreotti, Laurent Fauchier, et al.
Journal of the American Geriatrics Society|May 17, 2012
Effect of a mobile safety alarm on going outside, feeling safe, fear of falling, and quality of life in community-living older persons: a randomized controlled trialAlice C Scheffer, Wilma J Scholte op Reimer, Nynke van Dijk, et al.
Critical Care Medicine|April 7, 2007
Recombinant human activated protein C inhibits local and systemic activation of coagulation without influencing inflammation during Pseudomonas aeruginosa pneumonia in ratsGoda Choi, Jorrit-Jan H Hofstra, Joris J T H Roelofs, et al.
Journal of Critical Care|June 6, 2007
International integrated database for the evaluation of severe sepsis and drotrecogin alfa (activated) therapy: 28-day survival and safetyPierre-Francois Laterre, David R Nelson, William Macias, et al.
Transfusion|May 26, 2007
Recombinant human C1-inhibitor in the treatment of acute angioedema attacksGoda Choi, Maarten R Soeters, Henriette Farkas, et al.
Pageof 40

Showing results (301-310 of 394) with videos related to

Sort By:
Pageof 40
BMC Pulmonary Medicine|August 17, 2012
Early intravenous unfractionated heparin and outcome in acute lung injury and acute respiratory distress syndrome: a retrospective propensity matched cohort studyJorrit J Hofstra, Alexander P J Vlaar, David J Prins, et al.
British Journal of Haematology|February 12, 2004
Recombinant factor VIIa reverses the anticoagulant effect of the long-acting pentasaccharide idraparinux in healthy volunteersNick R Bijsterveld, Roel Vink, Benien E van Aken, et al.
Critical Care Medicine|May 9, 2012
Endogenous tissue-type plasminogen activator impairs host defense during severe experimental Gram-negative sepsis (melioidosis)*Liesbeth M Kager, W Joost Wiersinga, Joris J T H Roelofs, et al.
Thrombosis and Haemostasis|December 18, 2015
Supportive management strategies for disseminated intravascular coagulation. An international consensusAlessandro Squizzato, Beverley J Hunt, Gary T Kinasewitz, et al.
American Journal of Respiratory Cell and Molecular Biology|April 19, 2008
Endogenous beta-adrenergic receptors inhibit lipopolysaccharide-induced pulmonary cytokine release and coagulationIda A J Giebelen, Masja Leendertse, Mark C Dessing, et al.
Thrombosis and Haemostasis|November 4, 2011
Bleeding risk assessment and management in atrial fibrillation patients. Executive Summary of a Position Document from the European Heart Rhythm Association [EHRA], endorsed by the European Society of Cardiology [ESC] Working Group on ThrombosisGregory Y H Lip, Felicita Andreotti, Laurent Fauchier, et al.
Journal of the American Geriatrics Society|May 17, 2012
Effect of a mobile safety alarm on going outside, feeling safe, fear of falling, and quality of life in community-living older persons: a randomized controlled trialAlice C Scheffer, Wilma J Scholte op Reimer, Nynke van Dijk, et al.
Critical Care Medicine|April 7, 2007
Recombinant human activated protein C inhibits local and systemic activation of coagulation without influencing inflammation during Pseudomonas aeruginosa pneumonia in ratsGoda Choi, Jorrit-Jan H Hofstra, Joris J T H Roelofs, et al.
Journal of Critical Care|June 6, 2007
International integrated database for the evaluation of severe sepsis and drotrecogin alfa (activated) therapy: 28-day survival and safetyPierre-Francois Laterre, David R Nelson, William Macias, et al.
Transfusion|May 26, 2007
Recombinant human C1-inhibitor in the treatment of acute angioedema attacksGoda Choi, Maarten R Soeters, Henriette Farkas, et al.
Pageof 40